| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 1.1202.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Orifarm Generics A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Aguettant Nordic ApS, Orifarm A/S, STADA Nordic ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Øresund Pharma ApS, Sun Pharmaceuticals Germany GmbH | 381.745.570 kr. | 21. oktober 2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Hameln Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, Glenmark Pharmaceuticals Nordic AB, Øresund Pharma ApS, Sandoz A/S, Orifarm A/S, Paranova Danmark A/S, Vingmed A/S, Abacus Medicine A/S, Paranova Danmark A/S | 148.085.649 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 1.700.a | Amgros I/S | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, Ferring Lægemidler A/S, Orifarm A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Orion Pharma A/S, Orion Pharma A/S, Ferring Lægemidler A/S, Orifarm A/S, Viatris ApS, AstraZeneca A/S, AstraZeneca A/S, FrostPharma AB, FrostPharma AB, Sanofi A/S, BioMarin International Limited, Takeda Pharma A/S, BioMarin International Limited, Chiesi Pharma AB, Øresund Pharma ApS, Takeda Pharma A/S, Viatris ApS, Øresund Pharma ApS | 419.427.587 kr. | 12. oktober 2026 |
| Amgros 2027 1.700.a | Amgros I/S | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, Ferring Lægemidler A/S, Orifarm A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Orion Pharma A/S, Orion Pharma A/S, Ferring Lægemidler A/S, Orifarm A/S, Viatris ApS, AstraZeneca A/S, AstraZeneca A/S, FrostPharma AB, FrostPharma AB, Sanofi A/S, BioMarin International Limited, Takeda Pharma A/S, BioMarin International Limited, Chiesi Pharma AB, Øresund Pharma ApS, Takeda Pharma A/S, Viatris ApS, Øresund Pharma ApS | 419.427.587 kr. | 12. oktober 2026 |
| Rammeaftale vedrørende levering af fentanyl placebo | Danish Ministry of Defence Acquisition and Logistics Organisation | Øresund Pharma ApS | 6.500.000 kr. | 27. maj 2026 |
| Bekendtgørelse med henblik på frivillig forudgående gennemsigtighed - rammeaftale vedrørende indkøb af fentanyl placebo | Danish Ministry of Defence Acquisition and Logistics Organisation | Øresund Pharma ApS | 5.100.000 kr. | 27. maj 2026 |